Introduction Erectile dysfunction (ED) affects to some degree approximately 52% of the male
population aged 40–70 years. Many men do not respond to, or are precluded from using …

The clinical landscape of Peyronie's disease is everchanging. There has been growing
interest in non-invasive therapeutic options that could assist patients with achieving a …

Background Peyronie's disease (PD) is a fibrotic condition of the penis characterized by
abnormal plaque formation. Intralesional collagenase Clostridium histolyticum (CCh) is …

Erectile dysfunction (ED) affects up to 50% of men to some degree and has a variety of
physiologic and psychologic causes, but many patients do not seek specialist treatment …

Background: The aim of study was to evaluate the impact of plaque calcification on
symptoms of patients with Peyronie's disease (PD) and to evaluate mental health in PD …

The prevalence of penile calcification in the population remains uncertain. This retrospective
multicenter study aimed to determine the prevalence and characteristics of penile …

Peyronie's disease (PD) affects the penile albuginea, resulting in penile deformity, pain,
erectile dysfunction (ED), and an anxious–depressive state. PD diagnosis involves a …

Introduction: Erectile dysfunction (ED) affects to some degree approximately 52% of the
male population aged 40–70 years. Many men do not respond to, or are precluded from …

Introduction La maladie de Lapeyronie (MLP) touche jusqu'à 9% de la population
masculine. Le diagnostic est facile, il est surtout clinique mais la prise en charge est assez …

Introdução: A doença de Peyronie (DP) é caracterizada pela formação de placas fibróticas
na túnica albugínea (TA) do pênis. Os tratamentos efetivos são limitados e a cirurgia …